TH54362A - Methods and mixtures using (+) Norosis aspire in combination with proton pump inhibitors or H2 receptor antagonists. - Google Patents
Methods and mixtures using (+) Norosis aspire in combination with proton pump inhibitors or H2 receptor antagonists.Info
- Publication number
- TH54362A TH54362A TH1000633A TH0001000633A TH54362A TH 54362 A TH54362 A TH 54362A TH 1000633 A TH1000633 A TH 1000633A TH 0001000633 A TH0001000633 A TH 0001000633A TH 54362 A TH54362 A TH 54362A
- Authority
- TH
- Thailand
- Prior art keywords
- mixtures
- methods
- proton pump
- norosis
- aspire
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 229940077716 histamine h2 receptor antagonists for peptic ulcer and gord Drugs 0.000 title 1
- 229940126409 proton pump inhibitor Drugs 0.000 title 1
- 239000000612 proton pump inhibitor Substances 0.000 title 1
- 239000000126 substance Substances 0.000 claims abstract 7
- 108091005477 5-HT3 receptors Proteins 0.000 claims abstract 3
- 102000035037 5-HT3 receptors Human genes 0.000 claims abstract 3
- 108091005482 5-HT4 receptors Proteins 0.000 claims abstract 3
- 108010083204 Proton Pumps Proteins 0.000 claims abstract 3
- 150000001875 compounds Chemical class 0.000 claims abstract 3
- 230000000694 effects Effects 0.000 claims abstract 3
- 238000011287 therapeutic dose Methods 0.000 claims 2
- 102000003710 Histamine H2 Receptors Human genes 0.000 claims 1
- 108090000050 Histamine H2 Receptors Proteins 0.000 claims 1
- 102000006270 Proton Pumps Human genes 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 208000028774 intestinal disease Diseases 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 208000018556 stomach disease Diseases 0.000 claims 1
- 208000007882 Gastritis Diseases 0.000 abstract 2
- 102100021904 Potassium-transporting ATPase alpha chain 1 Human genes 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000000936 intestine Anatomy 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 101150056637 Hrh2 gene Proteins 0.000 abstract 1
Abstract
DC60 (12/05/43) การประดิษฐ์นี้เกี่ยวกับวิธีและสารผสมสำหรับป้องกัน, รักษา, หรือจัดการกับโรคกระเพาะ อาหารและลำไส้หรืออาการ ของโรคเหล่านั้น, โดยใช้สารหรือสารประกอบ 2 หรือมากกว่า 2 ชนิด เพื่อให้การแสดงฤทธิ์ที่ตำแหน่ง 3 ตำแหน่งบนตัวรับ 5-HT3, ตัวรับ 5-HT4, และอย่างน้อยที่สุด หนึ่งตำแหน่งของ ตัวรับ H2 และปั๊มพ์ของโปรตอน การประดิษฐ์นี้เกี่ยวกับวิธีและสารผสมสำหรับป้องกัน, รักษา, หรือจัดการกับโรคกระเพาะ อาหารและลำไส้หรืออาการ ของโรคเหล่านั้น, โดยใช้สารหรือสารประกอบ 2 หรือมากกว่า 2 ชนิด เพื่อให้การแสดงฤทธิ์ที่ตำแหน่ง 3 ตำแหน่งบนตัวรับ 5-HT3, ตัวรับ 5-HT4, และอย่างน้อยที่สุด หนึ่งตำแหน่งของ ตัวรับ H2 และปั๊มพ์ของโปรตอน สิทธิบัตรยา DC60 (12/05/43) This invention deals with methods and mixtures for preventing, treating, or managing gastritis. Food and intestines or symptoms Of those diseases, using two or more substances or compounds to give their activity at 3 positions on the 5-HT3 receptor, the 5-HT4 receptor, and at least the One position of the H2 receiver and the proton pump. This invention is about methods and mixtures for preventing, treating, or managing gastritis. Food and intestines or symptoms Of those diseases, using two or more substances or compounds to give their activity at 3 positions on the 5-HT3 receptor, the 5-HT4 receptor, and at least the One position of the H2 receptor and the proton pump.
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH54362A true TH54362A (en) | 2002-12-12 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Moore | Coronary risks associated with diclofenac and other NSAIDs: an update | |
| Scott et al. | Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations | |
| Tarikci et al. | Pruritus in systemic diseases: a review of etiological factors and new treatment modalities | |
| DK2488170T3 (en) | FORMATIONS comprising tramadol and celecoxib, FOR THE TREATMENT OF PAIN | |
| CN103860541A (en) | Selective androgen receptor modulators for treating diabetes | |
| CY1112376T1 (en) | 2,3,4,9-tetrahydro-1H-carvasol derivative as CRTH2 receptor antagonists | |
| EA200401317A1 (en) | COMPOSITIONS AND METHODS OF LIPOS DOSING OF CERTAIN DIMENSIONS FOR THE TREATMENT OR PREVENTION OF DISEASE | |
| Rosenberg et al. | Treatment of painful diabetic peripheral neuropathy | |
| US20240016790A1 (en) | Methods of using a phenoxypropylamine compound to treat pain | |
| Zwolinski et al. | ERAS protocol options for perioperative pain management of substance use disorder in the ambulatory surgical setting | |
| Balducci et al. | Palliative care in older patients with cancer | |
| CN106456637B (en) | Pharmaceutical uses of (S)-pyridindole and pharmaceutically acceptable salts thereof | |
| BRPI0416882A (en) | compound, pharmaceutical composition, method of treating a disorder, and use of a compound | |
| Coppens et al. | Adjuvants for balanced anesthesia in ambulatory surgery | |
| RU2007119067A (en) | MEANS FOR TREATMENT OF AN IRRITATED INTESTINAL SYNDROME WITH PREVENTION OF DIARRHEA | |
| EA200500941A1 (en) | MEANS FOR TREATING JOINT DISEASES | |
| ATE297732T1 (en) | COMBINATION THERAPY FOR THE TREATMENT OF HEART FAILURE | |
| TH54362A (en) | Methods and mixtures using (+) Norosis aspire in combination with proton pump inhibitors or H2 receptor antagonists. | |
| RU2003130641A (en) | KAPPA-OPIATE AGONISTS FOR TREATMENT OF DISEASES OF THE BLADDER | |
| Arnstein | The future of topical analgesics | |
| EA200800075A1 (en) | DOSING CIRCUIT FOR WISE | |
| Altarifi et al. | Preclinical comparison of antinociceptive effects between ibuprofen, diclofenac, naproxen, and acetaminophen on acid-stimulated body stretching and acid-depressed feeding behaviors in rats | |
| Bonomi et al. | Assessment and management of mucositis in head and neck cancer patients | |
| TH54363A (en) | Methods and mixtures used (-) Norosis aspired in combination with proton or H2 receptor antagonist bump inhibitors. | |
| IS8373A (en) | Use of oxcarbazepine to treat diabetes due to diabetes mellitus and to improve sleep |